|
Pronunciation |
|
(hye
DRAL a zeen & hye droe klor
oh THYE a zide) |
|
|
U.S. Brand
Names |
|
Apresazide® |
|
|
Generic
Available |
|
Yes |
|
|
Synonyms |
|
Hydrochlorothiazide and Hydralazine |
|
|
Pharmacological Index |
|
Antihypertensive Agent, Combination |
|
|
Use |
|
Management of moderate to severe hypertension and treatment of congestive
heart failure |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Usual Dosage |
|
Adults: Oral: 1 capsule twice daily |
|
|
Cardiovascular
Considerations |
|
Combination therapy for the treatment of hypertension should be
individualized for each patient. Potential advantages for hydralazine and
hydrochlorothiazide combination therapy may include improved compliance and
synergistic reductions in blood pressure with an accompanied reduction in side
effects. Thiazide therapy improves cardiovascular outcomes in patients with
hypertension. Hydralazine, in combination with isosorbide dinitrate, and
hydrochlorothiazide are also used in management of heart
failure. |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
See individual agents. Pregnancy precautions: Inform prescriber if
you are or intend to get pregnant. |
|
|
Dosage Forms |
|
Capsule:
50/50: Hydralazine hydrochloride 50 mg and hydrochlorothiazide 50 mg
100/50: Hydralazine hydrochloride 100 mg and hydrochlorothiazide 50 mg
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|